Document Detail


In vivo 2-amino-3-phosphonopropionic acid administration to neonatal rats selectively inhibits metabotropic excitatory amino acid receptors ex vivo in brain slices.
MedLine Citation:
PMID:  20504719     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
In previous work we found that 2-amino-3-phosphonopropionic acid, the ?-phosphono-substituted analog of aspartic acid, is a selective in vitro inhibitor of the excitatory amino acid agonist [ibotenate, quisqualate, trans(+/-)-1-amino-1,3-cyclopentanedicarboxylic acid (trans-ACPD)]-stimulated phosphoinositide hydrolysis. Here we investigated if the inhibitory effects of 2-amino-3-phosphonopropionic acid on metabotropic excitatory amino acid receptors could be observed in the ex vivo brain slice following in vivo administration to neonatal rats. In vitro addition of 2-amino-3-phosphonopropionic acid noncompetitively antagonized trans-ACPD-stimulated [(3)H]phosphoinositide hydrolysis in hippocampal slices from 9-day-old rats. Intraperitoneal (i.p.) administration of 2-amino-3-phosphonopropionic acid (250, 500 and 750 mg/kg) for two consecutive days (at 7 and 8 days of age) also produced dose-related inhibition of trans-ACPD-stimulated [(3)H]phosphomositide hydrolysis in hippocampal slices from 9-day-old rats. 2-Amino-3-phosphonopropionic acid (500 mg/kg x 2) inhibited quisqualate, ibotenate, and glutamate activations of [(3)H]phosphoinositide hydrolysis, but had no effect on carbachol or norepinephrine stimulations. Thus, multiple in vivo dosing with 2-amino-3-phosphonopropionic acid produces selective inhibition of excitatory amino acid, but not nonexcitatory amino acid receptors coupled to phosphoinositide hydrolysis. 2-Amino-3-phosphonopropionic acid dosing could be used to inhibit the metabotropic excitatory amino acid receptor in vivo to study its function in the developing brain.
Authors:
D D Schoepp; B G Johnson
Related Documents :
1982209 - Protection by pyroglutamic acid and some of its newly synthesized derivatives against g...
7882049 - Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory.
19268309 - The role of kynurenines in disorders of the central nervous system: possibilities for n...
8104419 - Extracellular ionic and volume changes: the role in glia-neuron interaction.
18977379 - Comparative toxicity to mice of domoic acid and isodomoic acids a, b and c.
1202389 - Neurochemical aspects of post-tetanic potentiation of monosynaptic reflexes in the cat ...
11975529 - Diastereoselective synthesis and estimation of the conformational flexibility of 6-oxop...
15575789 - Selenium-catalyzed halolactonization: nucleophilic activation of electrophilic halogena...
17052749 - Compositional analysis of dairy products derived from clones and cloned transgenic cattle.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurochemistry international     Volume:  18     ISSN:  0197-0186     ISO Abbreviation:  Neurochem. Int.     Publication Date:  1991  
Date Detail:
Created Date:  2010-05-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006959     Medline TA:  Neurochem Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  411-7     Citation Subset:  -    
Affiliation:
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, U.S.A.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor anta...
Next Document:  Bradykinin-induced phosphoinositide-dependent responses in protein kinase C down-regulated NCB-20 ce...